Alamar Biosciences, Inc. (California) (ALMR)
32.15
-5.98
(-15.68%)
USD |
NASDAQ |
Oct 06, 16:00
32.26
+0.11
(+0.34%)
After-Hours: 20:00
Alamar Biosciences Cash from Operations (Quarterly) : -11.32M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.32M |
| March 31, 2026 | -20.35M |
| Date | Value |
|---|---|
| June 30, 2025 | -11.88M |
| March 31, 2025 | -13.07M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| 10X Genomics, Inc. | 16.97M |
| Personalis, Inc. | -25.77M |
| Adaptive Biotechnologies Corp. | -6.40M |
| Champions Oncology, Inc. | -0.492M |
| Medpace Holdings, Inc. | 162.01M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -120.80M |
| Cash from Financing (Quarterly) | 201.84M |
| Free Cash Flow | -63.24M |
| Free Cash Flow Per Share (Quarterly) | -0.2172 |
| Free Cash Flow to Equity (Quarterly) | 274.07M |
| Free Cash Flow to Firm (Quarterly) | -14.85M |
| Free Cash Flow Yield | -2.84% |